ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,553Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 113

$695K Total Retail Price of All Prescriptions

Rank: 9 out of 113

661 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 661 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 661 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 11,712 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 704 628 1 1
SIMVASTATIN 541 495 2 2
LISINOPRIL 518 481 3 3
AMLODIPINE BESYLATE 486 468 4 4
HYDROCODONE-ACETAMINOPHEN 343 272 S3 5 7
ATENOLOL 329 310 6 16
PRAVASTATIN SODIUM 305 260 7 23
HYDROCHLOROTHIAZIDE 297 262 8 9
LOSARTAN POTASSIUM 296 283 9 13
OMEPRAZOLE 280 228 10 5
METOPROLOL SUCCINATE 269 264 11 10
FUROSEMIDE 263 242 12 6
WARFARIN SODIUM 247 220 13 8
CITALOPRAM HBR 241 211 14 17
METFORMIN HCL 240 220 15 11
SERTRALINE HCL 202 146 16 21
GABAPENTIN 198 153 17 18
ATORVASTATIN CALCIUM 180 162 18 15
ALENDRONATE SODIUM 179 169 19 22
METOPROLOL TARTRATE 170 151 20 14
POTASSIUM CHLORIDE 169 156 21 12
TRAMADOL HCL 163 133 22 29
SPIRONOLACTONE 144 142 23 32
ZOLPIDEM TARTRATE 144 129 23 19
MELOXICAM 139 118 25 44
FLUOXETINE HCL 128 84 26 31
TRIAMTERENE-HCTZ 124 107 27 26
DONEPEZIL HCL 117 117 28 33
ALLOPURINOL 114 99 29 20
GLIMEPIRIDE 113 90 30 36
FLUTICASONE PROPIONATE 110 66 31 39
DIOVAN 109 109 32 42
FENTANYL 107 87 S2 33 43
FENOFIBRATE 102 83 34 111
NEXIUM 101 84 35 47
PANTOPRAZOLE SODIUM 93 67 36 52
CYCLOBENZAPRINE HCL 90 48 R 37 76
DIGOXIN 87 87 38 27
MIRTAZAPINE 80 80 39 71
ROPINIROLE HCL 79 58 40 67
ADVAIR DISKUS 77 58 41 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 67 42 34
CLONIDINE HCL 74 74 42 74
LOSARTAN-HYDROCHLOROTHIAZIDE 71 63 44 40
LANTUS 66 65 45 38
TRAZODONE HCL 65 37 46 41
PEN NEEDLE 64 44 47 94
VENLAFAXINE HCL ER 63 59 48 55
BUPROPION HCL SR 63 49 48 153
NAMENDA 61 61 50 48
LYRICA 59 32 51 83
CELEBREX 58 48 52 90
CIPROFLOXACIN HCL 58 55 52 63
PREMARIN 56 55 R 54 69
SYNTHROID 56 53 54 57
ENALAPRIL MALEATE 56 53 54 50
CHLORTHALIDONE 55 55 57 78
CRESTOR 55 52 57 30
PAROXETINE HCL 54 50 59 45
FAMOTIDINE 53 34 60 71
CARVEDILOL 53 48 60 25
FELODIPINE ER 52 52 62 95
GLIPIZIDE 51 48 63 75
SPIRIVA 51 51 63 54
CLOPIDOGREL 50 48 65 56
PLAVIX 50 46 65 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.